U.S., June 4 -- ClinicalTrials.gov registry received information related to the study (NCT07622394) titled 'Structured Cardio-Oncology Rehabilitation for Cardiovascular Outcomes in Cancer Survivors' on May 15.
Brief Summary: Cancer therapy-related cardiac dysfunction (CTRCD) has become a major cause of morbidity and mortality among cancer survivors. Although cardiac rehabilitation is recommended for cardiovascular disease prevention and management, high-quality randomized controlled evidence regarding its efficacy in cardio-oncology populations remains limited.
This multicenter, prospective, parallel-group, superiority randomized controlled trial aims to evaluate whether a structured cardio-oncology rehabilitation (CORE) program combined ...